TICKVALE
>⌘K
NYSE · CIK 0000200406 · PHARMACEUTICAL PREPARATIONS

Johnson & Johnson

JNJ chart by TradingView
P/E 29.5xP/B 7.3xP/SALES 6.3xEV/EBITDA FCF YIELD 3.58%

PRICE HISTORY

LIVE · NYSE
JNJ chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$94.2B
EBITDA
FREE CASH FLOW
$19.7B
EPS
$11.03
GROSS MARGIN
67.88%
ROIC
25.95%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

29.5x
+43%
LATEST · Q2 FY26
29.5xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
9.3x294.2x

P / SALES (TTM)

6.3x
+38%
LATEST · Q2 FY26
6.3xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
4.0x6.3x

P / BOOK

7.3x
+62%
LATEST · Q2 FY26
7.3xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
4.5x7.3x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EV / REVENUE (TTM)

6.5x
+40%
LATEST · Q2 FY26
6.5xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
4.1x6.5x

FCF YIELD (TTM)

3.58%
-0.6pp
LATEST · Q2 FY26
3.58%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.02%6.01%

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$25.3B
+42%
LATEST · Q2 FY26
25.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$5.5B
+30%
LATEST · Q2 FY26
5.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$2.27
+48%
LATEST · Q2 FY26
2.27Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

6.60%
+2.4pp
LATEST · Q2 FY26
6.60%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-56.53%70.51%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

28.82%
+2.9pp
LATEST · Q2 FY26
28.82%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
6.09%44.19%

RETURN ON CAPITAL

20.65%
+0.2pp
LATEST · Q2 FY26
20.65%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
1.59%55.26%

RETURN ON EQUITY (TTM)

24.76%
+2.9pp
LATEST · Q2 FY26
24.76%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
1.97%54.95%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN68.19%
OPERATING MARGIN
NET MARGIN21.86%
FCF MARGIN28.82%
139.4086.9134.43-18.06-70.54GROSSNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$7.3B
+58%
LATEST · Q2 FY26
7.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.5B
+104%
LATEST · Q2 FY26
0.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$1.3B
+79%
LATEST · Q2 FY26
1.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

2.44B
-12%
LATEST · Q2 FY26
2.44BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$20.4B
+12%
LATEST · Q2 FY26
20.4BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

$37.3B
+59%
LATEST · Q2 FY26
37.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 76.96%INSIDERS 0.05%OTHER / RETAIL 22.99%5,761 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.8.85%213.4M$55.32B+2.2%
Vanguard Capital Management LLC6.50%156.6M$40.60BNEW
State Street Corporation5.54%133.5M$34.60B-0.3%
Vanguard Portfolio Management LLC2.64%63.5M$16.47BNEW
JPMORGAN CHASE & CO2.62%63.1M$16.36B+7.8%
Geode Capital Management, LLC2.46%59.2M$15.34B+2.1%
Morgan Stanley1.86%44.7M$11.59B-3.5%
State Farm Mutual Automobile Insurance Co1.31%31.6M$8.19B+0.0%
Northern Trust Corporation1.22%29.3M$7.60B+0.1%
Bank of America Corporation1.06%25.5M$6.61B-9.9%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.